Philips reports Q3 sales of EUR 5.9 billion, a 14% improvement in Adjusted EBITA to EUR 649 million, and an 18% increase in net income to EUR 383 million
Third-quarter highlights
- Sales increased to EUR 5.9 billion, with consolidated comparable sales growth of 2% and the HealthTech portfolio growing by 5%
- Adjusted EBITA amounted to EUR 649 million, or 11.0% of sales, compared to 9.8% of sales in Q3 2015
- EBITA totaled EUR 567 million, or 9.6% of sales, compared to 7.4% of sales in Q3 2015
- Income from operations (EBIT) amounted to EUR 481 million, compared to EUR 342 million in Q3 2015
- Net income amounted to EUR 383 million, compared to EUR 324 million in Q3 2015
- Operating cash flow totaled EUR 500 million, compared to EUR 281 million in Q3 2015; free cash flow of EUR 280 million, compared to EUR 58 million in Q3 2015